Lv53
1440 积分 2023-04-25 加入
Diagnosis and Management of Multiple Myeloma: A Review
2天前
已完结
Multiple myeloma
2天前
已完结
Neoadjuvant Pertuzumab Biosimilar HLX11 versus Reference Pertuzumab for Early-Stage or Locally Advanced Breast Cancer: A Phase III Equivalence Trial
13天前
已完结
A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design
14天前
已完结
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
14天前
已完结
Clinical characteristics of long-term survivors of small cell lung cancer
21天前
已完结
求THE LANCET文章的附件,链接请见下方,谢谢!
1个月前
已完结
求THE LANCET Respiratory Medicine文章的附件,链接请见下方,谢谢!
1个月前
已完结
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
1个月前
已完结
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial
2个月前
已完结